Marquette Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.19K Hold
37
– – ﹤0.01% 448
2026
Q2
$2.49K Sell
37
-34
-48% -$2.27K ﹤0.01% 557
2026
Q1
$4.46K Buy
+71
New +$4.94K ﹤0.01% 377
2025
Q4
– Sell
-33
Closed -$2.22K – 754
2025
Q3
$2.22K Buy
+33
New +$2.61K ﹤0.01% 521
2022
Q2
– Sell
-4
Closed -$1K – 333
2022
Q1
$1K Buy
+4
New +$438 ﹤0.01% 294

Other funds holding DXCM

Marquette Asset Management's DXCM Position: Q3 2026 in Review

Marquette Asset Management held its DexCom (DXCM) position steady in Q3 2026 at 37 shares worth $3.19K. The position accounts for ﹤0.01% of the portfolio, ranked #448.

Marquette Asset Management first reported a position in DXCM in Q1 2022 and has held it in 5 quarters since. The position peaked at $4.46K in Q1 2026. 41 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Marquette Asset Management held 37 shares of DexCom worth $3.19K as of Q3 2026.
  • Marquette Asset Management left its DexCom share count unchanged in Q3 2026.
  • DexCom made up ﹤0.01% of Marquette Asset Management's portfolio in Q3 2026, its #448 holding.
  • Marquette Asset Management first reported a position in DexCom in Q1 2022 and has held it in 5 quarters since.
  • Marquette Asset Management's DexCom position peaked at $4.46K in Q1 2026.
  • 41 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Marquette Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.